Sherbrooke Park Advisers LLC Mannkind Corp Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Mannkind Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 36,600 shares of MNKD stock, worth $133,956. This represents 0.09% of its overall portfolio holdings.
Number of Shares
36,600
Previous 48,186
24.04%
Holding current value
$133,956
Previous $310 Million
40.58%
% of portfolio
0.09%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding MNKD
# of Institutions
258Shares Held
172MCall Options Held
1.37MPut Options Held
241K-
Black Rock Inc. New York, NY22.6MShares$82.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$66.5 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$34.7 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$32 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$28.5 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $942M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...